Milestone Achieved as Immunotherapeutic Agent Under Investigation for the Treatment of Ovarian Cancer Added to Asset PortfolioTAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB ...

Cyte-09 Chassis Blueprint: Höllvanian Pitchweave Fragment x200, Experimental Arc-Relay x6, Techrot Motherboard x8, Alloy Plate x1000, and 15000 Credits. It takes 12 hours (real time) to be completed.

Strategic Decision to Support Improved Investor Profile and Potential Future Uplisting of Securities to Major ExchangeTAMPA, Fla., June 13, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a ...

--H-CYTE Inc. the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute, announces it has raised $6 million in new funding.

Shares of H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) traded down 49.5% on Tuesday .The company traded as low as $2.02 and last traded at $2.02. 400 shares changed hands during mid-day ...

TAMPA, Fla., Sept. 29, 2020 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a developer of regenerative cellular therapeutics, announced today that Robert Greif has been named the company’s new ...